Pharmaceutical Equipment Qualification Case Study

Speech Marks 99 GxP Consultancy.png

Every qualification project is an opportunity to simplify complexity. By combining regulatory rigour with operational insight, we help our clients turn compliance into a competitive advantage.   

~Rephine Qualification Lead Consultant

REPHINE SPEECH MARKS CLOSE GXPCONSULTANCY

About this Case Study

In this case study, we explore how Rephine partnered with a global pharmaceutical manufacturer to qualify both new and legacy equipment at a renovated thyroid API production facility. With complex systems, tight regulatory deadlines, and internal resource constraints, the client required a practical, compliant strategy to restart operations without delays.

Rephine’s qualification experts implemented a risk-based approach aligned with GMP and Annex 15 guidelines, enabling the client to:

  • Streamline IQ/OQ execution by integrating supplier testing
  • Reduce documentation workload through modular, reusable protocols
  • Improve traceability and process consistency across systems
  • Pass internal audits with zero observations
  • Establish a framework for future requalification

Over a six-month period, Rephine helped the site achieve full GMP compliance while significantly accelerating the equipment qualification timeline—delivering measurable value from day one.

Download the full case study to see how Rephine transformed complex qualification challenges into a scalable, compliant, and time-saving solution.

Equipment qualification Case Study mock up

Download the Case Study

View other our other resources and company news

Ensuring Compliance and Data Integrity in Pharmacovigilan Case Study

GMP Consultancy for a New Manufacturing Plant

With only a small team and a highly automated process, this biotech company needed to achieve EU GMP compliance fast. This case study shows how ...
Read More
ICH E6 Guide Header Image (1500 x 844 px) Article

Why Quality Can No Longer Live in Silos

Discover why siloed quality management is no longer sustainable in life sciences. Learn how integrating audits, advisory services and digital quality systems supports continuous GxP ...
Read More
QMS IMP Header image Blog case study May 25 Article

Why Most QMS Implementations Fail to Deliver Long-Term Value

Implementing a QMS is more than deploying software. Learn why most QMS implementations fall short, and what successful life sciences teams do differently to achieve ...
Read More
Ensuring Compliance and Data Integrity in Pharmacovigilan Case Study

Driving Global QMS Harmonisation for a Pharmaceutical Company

This case study outlines how Rephine helped a global pharmaceutical group implement and validate a harmonised Quality Management System across more than seventy sites. It ...
Read More
Banner Resource Hub Web Guide

How to Structure MDR Technical Documentation (Annex II & III). A Practical Compliance Guide

This white paper provides a practical guide to structuring MDR Technical Documentation under Annex II and Annex III. It explains how to organise evidence, maintain ...
Read More
CSV Blog

IT Quality Assurance in Regulated Life Sciences: Key Insights

IT Quality Assurance is pivotal in regulated life sciences. From CSV and data integrity to change control and audit readiness, discover how IT QA ensures ...
Read More
Ensuring Compliance and Data Integrity in Pharmacovigilan General

Practical compliance and inspection readiness for UK pharmaceutical quality systems

Explore how UK pharmaceutical and biotech organisations can stay prepared for MHRA, EMA and FDA inspections. This session provides expert guidance on inspection trends, compliance ...
Read More
Ensuring Compliance and Data Integrity in Pharmacovigilan Case Study

Supporting Verification and Validation of a Medical Device Software (MDSW)

Discover how a medical device start‑up successfully verified and validated its new Medical Device Software in line with MDR requirements. With Rephine’s structured approach to ...
Read More
BANNER Practical Guide to Post Market Surveillance PMS under EU MDR IVDR CSV

Practical Guide to the EMA’s Draft EU GMP Revisions

The EU’s new Product Liability Directive (2024/2853) changes who can be held liable and what damages can be claimed. From software and data loss to ...
Read More
Contact Us

Strengthen Your Assurance Journey

GMP Chapter 22 Adapting to Hybrid Documentation Standards